- Home
- ECDA vs INKT Comparison
ECDA vs INKT Comparison
Compare ECDA & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECDA
- INKT
- Stock Information
- Founded
- ECDA 2013
- INKT 2017
- Country
- ECDA United States
- INKT United States
- Employees
- ECDA N/A
- INKT N/A
- Industry
- ECDA Auto Manufacturing
- INKT Medicinal Chemicals and Botanical Products
- Sector
- ECDA Consumer Discretionary
- INKT Health Care
- Exchange
- ECDA Nasdaq
- INKT Nasdaq
- Market Cap
- ECDA 11.5M
- INKT 28.9M
- IPO Year
- ECDA N/A
- INKT 2021
- Fundamental
- Price
- ECDA $0.29
- INKT $7.04
- Analyst Decision
- ECDA
- INKT Strong Buy
- Analyst Count
- ECDA 0
- INKT 2
- Target Price
- ECDA N/A
- INKT $37.50
- AVG Volume (30 Days)
- ECDA 14.4M
- INKT 14.7K
- Earning Date
- ECDA 08-18-2025
- INKT 08-12-2025
- Dividend Yield
- ECDA N/A
- INKT N/A
- EPS Growth
- ECDA N/A
- INKT N/A
- EPS
- ECDA N/A
- INKT N/A
- Revenue
- ECDA $24,597,358.00
- INKT N/A
- Revenue This Year
- ECDA $21.59
- INKT N/A
- Revenue Next Year
- ECDA N/A
- INKT N/A
- P/E Ratio
- ECDA N/A
- INKT N/A
- Revenue Growth
- ECDA 3.46
- INKT N/A
- 52 Week Low
- ECDA $0.24
- INKT $4.56
- 52 Week High
- ECDA $1.35
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- ECDA 41.91
- INKT 47.56
- Support Level
- ECDA $0.25
- INKT $6.91
- Resistance Level
- ECDA $0.30
- INKT $7.51
- Average True Range (ATR)
- ECDA 0.06
- INKT 0.32
- MACD
- ECDA -0.00
- INKT -0.02
- Stochastic Oscillator
- ECDA 4.86
- INKT 27.28
About ECDA ECD Automotive Design Inc.
ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.